Month: March 2023

MacroGenics Provides Corporate Update and 2022 Financial Results

Written by Customer Service on March 15, 2023. Posted in Earnings Releases And Operating Results.

Cash runway extended through 2025 with $250 million in non-dilutive funding over past eight months TAMARACK study design modified with objective of accelerating data readout Encouraging lorigerlimab (PD-1 × CTLA-4 bispecific DART® molecule) monotherapy clinical data presented at ASCO-GU Conference call scheduled for today at 4:30 p.m. ETROCKVILLE, Md., March 15, 2023 (GLOBE NEWSWIRE) — MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today provided an update on its recent corporate progress and reported financial results for the year ended December 31, 2022. “Our recent presentation of encouraging, preliminary lorigerlimab data in patients with metastatic castration-resistant prostate cancer (mCRPC) at...

Capricor Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Written by Customer Service on March 15, 2023. Posted in Earnings Releases And Operating Results.

-Enrollment Continues to Progress in HOPE-3, the Phase 3 Clinical Trial of CAP-1002 in Duchenne Muscular Dystrophy (DMD); Plan to Report on Interim Analysis in Q4 2023- -Held Type-B CMC Meeting with U.S. Food and Drug Administration (FDA) Regarding Pathway Towards Biologics License Application (BLA) for CAP-1002 in DMD- -Expanded Partnership with Nippon Shinyaku to Japan to Leverage Commercial DMD Franchise with $12 Million Upfront and Additional Potential Milestone Payments of up to $89 Million- -To Host Conference Call and Webcast Today at 4:30 p.m. ET- SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases, announced today...

Vaxart Provides Business Update and Full Year 2022 Financial Results

Written by Customer Service on March 15, 2023. Posted in Earnings Releases And Operating Results.

Prioritizing oral bivalent norovirus candidate, one of the most advanced norovirus vaccines in development Will continue preclinical development of novel COVID-19 vaccine constructs to enhance cross-reactivity and potency with the goal of developing a pan-betacoronavirus vaccine Portfolio prioritization extends cash runway into Q2 2024 Conference call today at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., March 15, 2023 (GLOBE NEWSWIRE) — Vaxart, Inc. (NASDAQ: VXRT) issued its business update today for the full year 2022, during which Vaxart announced it is prioritizing development of the Company’s bivalent norovirus candidate. “After completing six norovirus clinical trials, we are encouraged by the robust immunogenicity data in both young adult and elderly populations and the encouraging safety profile of our oral norovirus program....

Patriot Battery Metals Announces C$50M Flow-Through Financing

Written by Customer Service on March 15, 2023. Posted in Public Companies.

Not for Distribution to U.S. News Wire Services or for Dissemination in the U.S. HighlightsC$50 million raise to accelerate critical mineral exploration on Corvette PropertyPrivate placement of flow through shares conducted at price of C$22.57 representing a 90% premium to the Company’s last traded share price on TSX-V as of Monday, 13 March 2023Strong demand from existing and new institutional, professional and sophisticated investorsPlacement completed via issuing of CDI’s increasing the liquidity on the ASXProceeds will be used to accelerate exploration on the Corvette Lithium Project Initial mineral resource for CV5 targeted for the June 2023Blair Way, the Company’s President, CEO, & Director, comments: “The Corvette Property is shaping up as an extraordinary discovery and the strong support shown for this capital...

Nokia Corporation: Repurchase of own shares on 15.03.2023

Written by Customer Service on March 15, 2023. Posted in Public Companies.

Nokia CorporationStock Exchange Release15 March 2023 at 21:00 EET Nokia Corporation: Repurchase of own shares on 15.03.2023 Espoo, Finland – On 15 March 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 319,371 4.28CEUX 3,855 4.25AQEU 786 4.37TQEX 1,088 4.28Total 325,100 4.28* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014...

MBG Holdings Secures Contract to Design and Build Cellular and Fiber Networks for TechFort, a New Tech Hub in the U.K.

Written by Customer Service on March 15, 2023. Posted in Public Companies.

AUSTIN, TX, March 15, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – MBG Holdings, Inc (OTC Pink: MBGH), holding company of Onepath systems and AMR Resources, LLC, a leading telecommunications lifecycle company, secured a contract to design, build and deploy the cellular and fiber networks for TechFort, a large-scale, much-anticipated development in Dover, England, UK. MBG has the sole rights to develop the fiber, the conduit, neutral host cellular, and private 5G cellular for the 40-acre campus with office space, multifamily homes, entertainment venues, and more. Situated on the British coast overlooking the port of Dover, TechFort is an ambitious construction and renovation project that repurposes the famous Western Heights, a series of Napoleon-era fortresses, into an advanced technology hub. MBG will develop and operate a neutral-host...

Noranda Income Fund Announces Completion of Acquisition by Glencore

Written by Customer Service on March 15, 2023. Posted in Mergers And Acquisitions.

TORONTO, March 15, 2023 (GLOBE NEWSWIRE) — Noranda Income Fund (TSX: NIF.UN) (the “Fund”) today announced that the previously announced acquisition by Glencore Canada Corporation (“Glencore”) of all of the issued and outstanding priority units of the Fund for C$1.98 per priority unit by way of a plan of arrangement under the Business Corporations Act (Ontario) and the Trustee Act (Ontario) (the “Arrangement”) was completed. Immediately prior to the Arrangement, Glencore owned 12,500,000 special units of the Fund representing approximately 25% of the 49,989,975 issued and outstanding units of the Fund. As a result of the Arrangement, Glencore acquired all of the 37,489,975 issued and outstanding priority units of the Fund. Following completion of the Arrangement, Glencore owns 100% of the issued and outstanding units of the Fund. Computershare...

Todos Medical Supports Long COVID Awareness Day

Written by Customer Service on March 15, 2023. Posted in Public Companies.

NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, March 15, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced its support for International Long COVID Awareness Day. Todos Medical is fully aligned with the Long COVID community and its effort to boost awareness, as well as calls for additional resources to be invested to fight this potentially debilitating condition. Social media platforms around the world are hosting special online events, highlighting the impact this disease has had on everyday living. The hashtags #LongCovid and #LongCovidAwarenessDay are being circulated to facilitate much needed dialogue on the topic. “There are tens of millions of people affected by Long COVID syndrome, post-acute sequelae of...

Hyloris reports full year results for 2022 & provides business outlook

Written by Customer Service on March 15, 2023. Posted in Earnings Releases And Operating Results.

Strong R&D progress & attractive commercial deals, including additional Tranexamic Acid RTU out-licensing deals Potential U.S. market approval for Maxigesic® IV in H2 2023 Promising new product candidates driving innovation and on track for a planned acceleration towards a portfolio of 30 assets before 2025 Revenues of €3 million, net loss decreased to €10.8 million with increased R&D expenses €43 million in cash & cash equivalents, no financial debt Webcast at 1PM GMT / 2PM CET/ 9AM EST (register here)Liège, Belgium – REGULATED INFORMATION – 15 March 2023 – 7PM CET – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, today announces its financial and operational results for the year ending...

Toll Brothers Announces Lakeside at Cielo Ranch Model Grand Opening in Shady Shores, Texas

Written by Customer Service on March 15, 2023. Posted in Public Companies.

New boutique luxury community of just 29 homes features stunning architectural and interior designToll Brothers Lakeside at Cielo Ranch Toll Brothers announced its new model home in Lakeside at Cielo Ranch is now open in Shady Shores, Texas.SHADY SHORES, Texas, March 15, 2023 (GLOBE NEWSWIRE) — Toll Brothers, Inc (NYSE:TOL), the nation’s leading builder of luxury homes, today announced the grand opening of its model home at Lakeside at Cielo Ranch, a new community of luxury single-family homes in Shady Shores, Texas. The designer-decorated Artisan Hill Country model home is now open daily and available to tour at 1230 McClintock Drive in Shady Shores. The highly anticipated Lakeside at Cielo Ranch model home features innovative architecture and stunning interior design and merchandising, showcasing the perfect blend of luxury...

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals